FibroBiologics announces grant of a European patent
FibroBiologics (FBLG) announced it has been granted a European patent covering methods of enhancing fibroblast therapeutic activity.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity
Newly Granted Patent Covers Methods of Augmenting the Regenerative Efficacy of Fibroblasts Using Platelet Rich Plasma and Cytokines, with Claims Directed to Angiogenesis and Spinal Disc RegenerationHOUSTON, Sept. 29, 2026 // -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the…